索诺玛制药(NASDAQ:SNOA)报告季度每股亏损$(0.63)，优于分析师一致预期的$(0.69)，增长率为8.7%。这是比去年同期每股亏损$(1.60)增加了60.63%。公司报告季度销售额为$3.564，未达分析师一致预期的$4.060百万，差距为100.00%。这比去年同期的销售额$3.138百万下降了100.00%。
以上内容来自Benzinga Earnings专栏，原文如下：
Sonoma Pharmaceuticals (NASDAQ:SNOA) reported quarterly losses of $(0.63) per share which beat the analyst consensus estimate of $(0.69) by 8.7 percent. This is a 60.63 percent increase over losses of $(1.60) per share from the same period last year. The company reported quarterly sales of $3.564 which missed the analyst consensus estimate of $4.060 million by 100.00 percent. This is a 100.00 percent decrease over sales of $3.138 million the same period last year.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.